NanoCross™ Elite AB14W035080150Recalls & reported problems
Ev3, Inc · PTA AB14W035080150 NANOCROSS 014 V05 · Class 2
All models of NanoCross Elite (63)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00763000109967), received between Jul 9, 2019 and Mar 30, 2021 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Burst Container or Vessel” (1 report).
1 other recall cover devices cleared under the same FDA submission (K141118); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Burst Container or Vessel1
- Detachment of Device or Device Component1
- Difficult to Insert1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
- Patient Problem/Medical Problem1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionMar 30, 2021Difficult to Insert; Detachment of Device or Device Component; Difficult to Insert; Detachment of Device or Device Component
PHYSICIAN ATTEMPTED TO USE A NANOCROSS PTA BALLOON WITH A 6FR SHEATH AND 0.014 NON-MEDTRONIC GUIDEWIRE DURING TREATMENT OF A CALCIFIED AND PLAQUE 80MM LESION IN THE PATIENT¿S MID RIGHT TIBIAL/POPLITEAL TRUNK AND ANTERIOR TIBIAL ARTERY. VESSEL DIAMETER REPORTED AS 4MM. LESION EXHIBITED 65% STENOSIS. SLIGHT VESSEL TORTUOSITY AND MODERATE CALCIFICATION ARE REPORTED. THERE WAS NO DAMAGE NOTED TO THE PRODUCT PACKAGING. NO ISSUES WERE NOTED WHEN REMOVING THE DEVICE FROM THE PACKAGING. IFU WAS FOLLOWED AND THE DEVICE WAS PREPPED WITHOUT ISSUE. A NON-MEDTRONIC INFLATION DEVICE WITH A CONTRAST AND SALINE MIX WERE USED FOR BALLOON INFLATION. IT IS REPORTED THAT DURING ADVANCEMENT OF THE DEVICE OVER THE WIRE AND INTO THE SHEATH THE BALLOON DETACHED. THE DEVICE WAS REMOVED AS A UNIT AND ANOTHER WIRE AND BALLOON WERE USED TO COMPLETE THE PROCEDURE. NO PATIENT INJURY REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11588789 ↗InjuryJul 9, 2019Burst Container or Vessel; Burst Container or Vessel
IT WAS REPORTED THAT THE PHYSICIAN WAS USING A NANOCROSS PTA BALLOON TO TREAT A LESION IN THE MID RIGHT POPLITEAL ARTERY. THE LESION WAS DESCRIBED AS SEVERELY CALCIFIED, WITH SLIGHT TORTUOUSITY AND ABOUT 7CM IN LENGTH IN A VESSEL DESCRIBED AS APPROX. 3.5-4MM IN DIAMETER. THERE WAS NO DAMAGE NOTED TO THE PACKAGING AND THERE WERE NO ISSUES NOTED WHEN REMOVING THE DEVICE FROM THE TRAY/HOOP. THE DEVICE WAS PREPPED WITHOUT ISSUE. A 6FR NON-MEDTRONIC SHEATH AND A 0.014 NON-MEDTRONIC GUIDEWIRE WERE USED WITH NO EMBOLIC PROTECTION. IT WAS REPORTED THAT DURING THE SECOND INFLATION OF THE BALLOON TO 10ATM, THE BALLOON BURST. MOST FRAGMENTS OF THE BALLOON WERE RETRIEVED BY SNARE AND ONE FRAGMENT WAS CAGED WITH A STENT. NO PATIENT INJURY WAS REPORTED.
Patient problems: Patient Problem/Medical Problem
MAUDE report 8771315 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K141118. One submission often covers many models, so check the product and lot details in each record.
- Z-0904-2025 · Dec 10, 2024 · Open, ClassifiedMedtronic NanoCross Elite PTA catheter, REF numbers amd sizes: 1) AB14W050020090, Size: 5MM X 20MM X 90CM; 2) AB14W050020150, Size: 5MM X 20MM X 150CM; 3) AB14W050040090,
Other Catheter, angioplasty, peripheral, transluminal devices
- Coyote™ ES H74939135152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal879 reports
- Coyote™ ES H74939135204010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal585 reports
- Coyote™ ES H74939135202010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal437 reports
- Coyote™ ES H74939135304010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal384 reports
- Coyote™ ES H74939135404010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal293 reports
- Coyote™ ES H74939134152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal279 reports
- Coyote™ H74939185202210Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal200 reports
- Coyote™ ES H74939135254010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal127 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page